Mallory L. Hacker

Vanderbilt University Medical Center — United States

Medicine · Health Sciences

12h-index618citations45works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(30), Neurological disorders and treatments(30), Botulinum Toxin and Related Neurological Disorders(11), Genetic Neurodegenerative Diseases(8), Autism Spectrum Disorder Research(7)

Publications45 total

Factors influencing the long-term maintenance of spasticity neurotoxin treatment
Journal of the Neurological Sciences·2025
Exploring the Feasibility of Conducting Outpatient Dopaminergic Washouts in Early-Stage Parkinson's Disease: Patient Experiences and Perspectives
Parkinsonism & Related Disorders·2025
Early-stage Parkinson’s Disease Experiences with a Week-long Dopaminergic Medication Washout (P4-5.028)
Neurology·2025
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Journal of Neurology·2024· 3 citedOpen Access
Can a specific deep brain stimulation paradigm slow motor progression and provide long-term motor benefit in Parkinson’s disease?
Parkinsonism & Related Disorders·2024
Telehealth Follow-up for Cervical Dystonia Patients Treated with Neurotoxin Injection: Patient Reported Outcomes
Parkinsonism & Related Disorders·2024
Evaluating a Motor Progression Connectivity Model Across Parkinson’s Disease Stages
2024Open Access
Advances in Deep Brain Stimulation: From Mechanisms to Applications
Journal of Neuroscience·2023· 31 citedOpen Access
Eleven-year outcomes from the deep brain stimulation in early-stage Parkinson’s disease pilot clinical trial
Parkinsonism & Related Disorders·2023
Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease
Parkinsonism & Related Disorders·2023· 8 citedOpen Access
Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson Disease
Annals of Neurology·2023· 26 citedOpen Access
Eleven-Year Outcomes of Deep Brain Stimulation in Early-Stage Parkinson Disease
Neuromodulation Technology at the Neural Interface·2022· 14 citedOpen Access
Deep Brain Stimulation in Early-Stage Parkinson’s Disease: Patient Experience after 11 Years
Brain Sciences·2022· 11 citedOpen Access
Exploring the presence of multiple abnormal non-motor features in patients with cervical dystonia
Journal of Clinical Neuroscience·2021· 1 citedOpen Access
Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs
Clinical Neurology and Neurosurgery·2021· 10 citedOpen Access
Enhancing Performance of a Spasticity Screening Tool Using the Minimum Data Set
Journal of the American Medical Directors Association·2021
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease
Neuromodulation Technology at the Neural Interface·2021· 10 citedOpen Access
Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes
Neurology·2021
Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes
Neurology·2021
Long-Term Care Resident Awareness and Interest in Spasticity Treatments
Geriatrics·2021· 2 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

David Charles(37), Thomas L. Davis(21), Maxim Turchan(20), Peter E. Konrad(17), Fenna T. Phibbs(15), Peter Hedera(14), Amanda Currie(12), Jacqueline Meystedt(11), Lauren E. Heusinkveld(10), Kelly Harper(8), Anna Lia Molinari(7), Kian Pazira(7), Joseph S. Neimat(6), David Charles(5), Kevin R. Cannard(4), Jürgen Floege(4), Nanditha Rajamani(4), Aaditi G. Naik(4), David A. Isaacs(4), Shelby Ploucher(4)